Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jilin XING"'
Publikováno v:
Energies, Vol 16, Iss 17, p 6213 (2023)
Different types of shale-oil sweet spots have developed and are vertically stacked in multiple layers of the Qingshankou Formation in the Changling Depression, southern Songliao Basin. Furthermore, this area lacks a classification standard in the opt
Externí odkaz:
https://doaj.org/article/374531f916c247d28334193140df9ddb
Autor:
Bo LIU, Jiahui SUN, Yongqing ZHANG, Junling HE, Xiaofei FU, Liang YANG, Jilin XING, Xiaoqing ZHAO
Publikováno v:
Petroleum Exploration and Development, Vol 48, Iss 3, Pp 608-624 (2021)
The lithology, lithofacies, reservoir properties and shale oil enrichment model of the fine-grained sedimentary system in a lake basin with terrigenous clastics of large depression are studied taking the organic-rich shale in the first member of Cret
Externí odkaz:
https://doaj.org/article/c11788b1fcb74fb188442ca9467ec6ce
Publikováno v:
Frontiers in Earth Science, Vol 9 (2021)
A series of significant shale oil discoveries have been made recently in the Upper Cretaceous Qingshankou Formation in the Songliao Basin, providing a new resource target for shale oil exploration in Northeast China. In this context, an understanding
Externí odkaz:
https://doaj.org/article/fd66f1f180914eafa7277246acedee01
Publikováno v:
Cancer Medicine, Vol 8, Iss 16, Pp 7086-7097 (2019)
Abstract Recent advances in endocrine therapy have improved the prospects for estrogen receptor‐positive breast cancer. Tamoxifen is an effective drug for patients with estrogen receptor‐positive breast cancer, but the development of resistance i
Externí odkaz:
https://doaj.org/article/f680d48717f0413589f23f0d816dd225
Autor:
Xitao Chen, Xiaodi Sun, Jingqian Guan, Junda Gai, Jilin Xing, Lin Fu, Shuli liu, Feifei Shen, Keyan Chen, Wenya Li, Libo Han, Qingchang Li
Publikováno v:
Cellular Physiology and Biochemistry, Vol 44, Iss 6, Pp 2322-2336 (2017)
Background/Aims: The therapeutic efficacy of paclitaxel is hampered by chemotherapeutic resistance in non-small cell lung cancer (NSCLC). Rsf-1 enhanced paclitaxel resistance via nuclear factor-κB (NF-κB) in ovarian cancer cells and nasopharyngeal
Externí odkaz:
https://doaj.org/article/5375ec2de5274ff2a8faac3d370e0189
Publikováno v:
Biochemical and Biophysical Research Communications. 495:1158-1166
Lung cancer is the leading cause of cancer death worldwide, and most of all cases are non-small-cell lung cancer. Lung cancer is associated with dysregulation of mitochondrial fusion and fission, and inhibition of the fission regulator Dynamin-relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26063148e0dba2c72e341ecdfa15485
https://doi.org/10.1016/j.bbrc.2017.11.109
https://doi.org/10.1016/j.bbrc.2017.11.109
Autor:
Wenya Li, Libo Han, Feifei Shen, Jilin Xing, Junda Gai, Qingchang Li, Keyan Chen, Shuli Liu, Lin Fu, Xiaodi Sun, Xitao Chen, Jingqian Guan
Publikováno v:
Cellular Physiology and Biochemistry, Vol 44, Iss 6, Pp 2322-2336 (2017)
Background/Aims: The therapeutic efficacy of paclitaxel is hampered by chemotherapeutic resistance in non-small cell lung cancer (NSCLC). Rsf-1 enhanced paclitaxel resistance via nuclear factor-κB (NF-κB) in ovarian cancer cells and nasopharyngeal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2a9a890e1433b31295cf00e8bfd018b
https://www.karger.com/Article/FullText/486116
https://www.karger.com/Article/FullText/486116
Autor:
Yang, Liang1 (AUTHOR) yang-liang@petrochina.com.cn, Xing, Jilin1 (AUTHOR) xing-jl@petrochina.com.cn, Xue, Wei1 (AUTHOR) lukn@petrochina.com.cn, Zheng, Lehua2 (AUTHOR) s22010121@s.upc.edu.cn, Wang, Rui2 (AUTHOR) s22010125@s.upc.edu.cn, Xiao, Dianshi2 (AUTHOR) xiaods@upc.edu.cn
Publikováno v:
Energies (19961073). Sep2023, Vol. 16 Issue 17, p6213. 20p.
Autor:
Zhao-Xuan, Ding1 (AUTHOR), Ying, Wang1 (AUTHOR)
Publikováno v:
Journal of Macromolecular Science: Physics. 2021, Vol. 60 Issue 9, p647-662. 16p.
Autor:
Xing, Jilin1 (AUTHOR), Li, Ji1 (AUTHOR), Fu, Lin1 (AUTHOR), Gai, Junda1 (AUTHOR), Guan, Jingqian1 (AUTHOR), Li, Qingchang1 (AUTHOR) qcli@cmu.edu.cn
Publikováno v:
Cancer Medicine. Nov2019, Vol. 8 Issue 16, p7086-7097. 12p.